GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (OCSE:ORPHA) » Definitions » 6-1 Month Momentum %

Orphazyme AS (OCSE:ORPHA) 6-1 Month Momentum % : 37.93% (As of Apr. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Orphazyme AS 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-25), Orphazyme AS's 6-1 Month Momentum % is 37.93%.

The industry rank for Orphazyme AS's 6-1 Month Momentum % or its related term are showing as below:

OCSE:ORPHA's 6-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: 3.45 vs OCSE:ORPHA: 37.93

Competitive Comparison of Orphazyme AS's 6-1 Month Momentum %

For the Biotechnology subindustry, Orphazyme AS's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orphazyme AS's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's 6-1 Month Momentum % falls into.



Orphazyme AS  (OCSE:ORPHA) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orphazyme AS  (OCSE:ORPHA) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Orphazyme AS 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orphazyme AS (OCSE:ORPHA) Business Description

Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (OCSE:ORPHA) Headlines

No Headlines